TaurelFinance, decoded
Live
Loading market data…
TTaurel

markets

The latest markets headlines, updated continuously. · Page 17

Surging economy gets off to a good start in the fourth quarter — but there’s one big problem
markets14 days ago

Surging economy gets off to a good start in the fourth quarter — but there’s one big problem

Warning signs are emerging that consumers will be hit with rising prices.

MarketWatch

Over 40% of Americans are heading toward retirement ‘blind’ — with no plan
markets14 days ago

Over 40% of Americans are heading toward retirement ‘blind’ — with no plan

Nearly half of Americans haven’t calculated what they’ll need in retirement.

MarketWatch

Smart financial advisers are dropping ROI, NAV and QCD for plain English when talking to clients
markets14 days ago

Smart financial advisers are dropping ROI, NAV and QCD for plain English when talking to clients

Not everyone is familiar with the ABCs of financial planning

MarketWatch

It’s been a painful month for hedge funds. To turn it around, they are shorting U.S. stocks.
markets14 days ago

It’s been a painful month for hedge funds. To turn it around, they are shorting U.S. stocks.

In response to losses on popular trades, hedge funds are now shorting U.S. stocks aggressively to try and win back some performance.

MarketWatch

The mobile ambitions of SpaceX see telecom stocks get hit again. What the latest developments mean.
markets15 days ago

The mobile ambitions of SpaceX see telecom stocks get hit again. What the latest developments mean.

Reports of Starlink’s discussions with cell-tower owners were noticed by shareholders of Verizon, AT&T and T-Mobile.

MarketWatch

The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?
markets15 days ago

The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?

Tech stocks are slumping — even as more than 300 S&P 500 constituents rose Thursday — and Treasurys are rallying. Here’s what may be changing.

MarketWatch

France is getting its credit rating reviewed. What to expect as French debt turmoil has helped turn U.S. Treasury yields around.
markets15 days ago

France is getting its credit rating reviewed. What to expect as French debt turmoil has helped turn U.S. Treasury yields around.

Moody’s is set to update its rating on France’s debt after U.S. markets close on Friday.

MarketWatch

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?
markets15 days ago

‘She’s living the dream’: My stepmother said I can buy my childhood home for $850,000. Is she taking advantage of me?

“My late father bought our house for $250,000 in the 1990s.”

MarketWatch

This market signal just occurred for only the second time since 1999. Here’s what happened and what it means.
markets15 days ago

This market signal just occurred for only the second time since 1999. Here’s what happened and what it means.

An unusual occurrence with breadth and the stock market just occurred.

MarketWatch

This hot AI-fueled stock has been in a rut. It just beat earnings expectations by 36%.
markets15 days ago

This hot AI-fueled stock has been in a rut. It just beat earnings expectations by 36%.

A company beating earnings expectations by 36% and revenue expectations by 15% would usually see a postresults bump. But not for Bloom Energy, the fuel-cell maker that has flourished due to data-center demand.

MarketWatch

My spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair?
markets15 days ago

My spouse was awarded $90,000 from my 401(k) in our divorce. How is that fair?

“I retired in 2020 and subsequently went through a divorce a few years later.”

MarketWatch

NBA star Precious Achiuwa signs on for $1.8 million condo in luxury Miami tower
markets15 days ago

NBA star Precious Achiuwa signs on for $1.8 million condo in luxury Miami tower

Sacramento Kings forward Precious Achiuwa has signed for a $1.84M condo inside a lavish Miami development that has already attracted several high-profile athletes.

MarketWatch

CoreWeave set off a wave of anxiety — but Wall Street’s dire prognosis is premature
markets15 days ago

CoreWeave set off a wave of anxiety — but Wall Street’s dire prognosis is premature

Stop listening to market pundits and start looking at market performance.

MarketWatch

The U.S. stock market is fracturing into two camps, and it’s leaving investors with a brutal case of whiplash
markets15 days ago

The U.S. stock market is fracturing into two camps, and it’s leaving investors with a brutal case of whiplash

The artificial-intelligence trade is on the ropes. CNN’s “Fear & Greed” index is screaming fear, and the yield on the 10-year Treasury note just clinched its biggest daily drop since the collapse of Silicon Valley Bank.

MarketWatch

Treasury yields see extreme plunge. Why investors are ducking for cover.
markets15 days ago

Treasury yields see extreme plunge. Why investors are ducking for cover.

‘It’s a take-back trade,’ says PGIM’s Tipp. ‘Not an all-out fear of recession type of situation.’

MarketWatch

Americans are having fewer babies — and pampering them with luxury diapers
markets15 days ago

Americans are having fewer babies — and pampering them with luxury diapers

“Fewer babies in each household means parents spend more per baby,” Procter & Gamble’s CFO says.

MarketWatch

Oil prices approach Iran-war highs as soaring tanker rates trigger a second energy squeeze
markets15 days ago

Oil prices approach Iran-war highs as soaring tanker rates trigger a second energy squeeze

Wall Street may be starting to price in the scenario everyone fears: a full-scale regional conflict that could further choke off global energy supplies and unleash a fresh wave of turmoil across financial markets.

MarketWatch

Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
markets15 days ago

Moderna’s cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled

A ‘sell-the-news reaction’? The experimental treatment helped prevent the return of cancer or death in melanoma patients by 42% after two years.

MarketWatch

← NewerOlder →